Bioventus Inc Cl A (BVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 9,956 | 5,950 | -3,322 | -43,833 | -46,446 |
| Depreciation Amortization | 35,317 | 23,914 | 11,865 | 49,555 | 37,150 |
| Income taxes - deferred | 222 | 87 | 43 | -5,394 | -8,609 |
| Accounts receivable | -2,801 | -4,625 | 9,004 | -10,666 | -4,874 |
| Other Working Capital | -20,047 | -30,724 | -31,201 | -11,780 | -9,672 |
| Other Operating Activity | 14,058 | 12,005 | -5,720 | 60,913 | 51,924 |
| Operating Cash Flow | $36,705 | $6,607 | $-19,331 | $38,795 | $19,473 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,982 | -1,509 | -826 | -1,006 | -432 |
| Net Acquisitions | -686 | -686 | N/A | 24,678 | N/A |
| Purchase Of Investment | 0 | 0 | 0 | -709 | -709 |
| Investing Cash Flow | $-2,668 | $-2,195 | $-826 | $22,963 | $-1,141 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 76,907 | 15,000 | 15,000 | N/A | 0 |
| Debt Repayment | -91,067 | -10,000 | -5,000 | -59,584 | -11,320 |
| Common Stock Issued | 1,563 | 1,467 | 150 | 2,442 | 1,339 |
| Other Financing Activity | -21,096 | -20,183 | -9,203 | 2,562 | -1,744 |
| Financing Cash Flow | $-33,693 | $-13,716 | $947 | $-54,580 | $-11,725 |
| Exchange Rate Effect | 238 | 632 | 430 | -2,560 | -497 |
| Beginning Cash Position | 41,582 | 41,582 | 41,582 | 36,964 | 36,964 |
| End Cash Position | 42,164 | 32,910 | 22,802 | 41,582 | 43,074 |
| Net Cash Flow | $582 | $-8,672 | $-18,780 | $4,618 | $6,110 |
| Free Cash Flow | |||||
| Operating Cash Flow | 36,705 | 6,607 | -19,331 | 38,795 | 19,473 |
| Capital Expenditure | -1,982 | -1,509 | -826 | -1,006 | -432 |
| Free Cash Flow | 34,723 | 5,098 | -20,157 | 37,789 | 19,041 |